MDPI's Genes Journal Calls for Papers on Genetic Basis of Neuropsychiatric Disorders

MDPI's open-access journal Genes announces a Special Issue on the genetic basis of neuropsychiatric disorders, inviting researchers to submit original articles by May 11, 2024. The issue aims to advance understanding of the genetic factors underlying complex conditions like schizophrenia.

author-image
Bijay Laxmi
New Update
MDPI's Genes Journal Calls for Papers on Genetic Basis of Neuropsychiatric Disorders

MDPI's Genes Journal Calls for Papers on Genetic Basis of Neuropsychiatric Disorders

MDPI's open-access journal Genes has announced a Special Issue focused on exploring the genetic underpinnings of neuropsychiatric disorders. The journal is inviting researchers to submit original research articles, reviews, and short communications that shed light on shared genetic factors and comorbidities associated with these complex conditions. The submission deadline for the Special Issue is May 11, 2024.

Why this matters: Uncovering the genetic basis of neuropsychiatric disorders can lead to the development of more effective treatments and improved patient outcomes, ultimately reducing the significant social and economic burden of these conditions. Moreover, this research can also provide valuable insights into the underlying mechanisms of brain function and behavior, with potential applications in fields beyond psychiatry.

Neuropsychiatric disorders, such asschizophrenia, are multifaceted conditions that involve a complex interplay of genetic and environmental factors. Unraveling the genetic basis of these disorders is crucial for developing targeted treatments and improving patient outcomes. The Special Issue aims to gather cutting-edge research that advances our understanding of the genetic architecture underlying neuropsychiatric disorders.

The scope of the Special Issue encompasses a wide range of topics related to the genetic basis of neuropsychiatric disorders. Researchers are encouraged to submit manuscripts that explore shared genetic factors and comorbidities, gene expression and regulation, genetic association studies, functional genomics and epigenomics, and the use of cellular models such as iPSC-derived neurons.

A recent study published inGenes(2024, 15, 609) highlights the relevance of this Special Issue. The study investigated the role of the PDE4 family of enzymes in schizophrenia and found differential regulation of PDE4B in brain tissues and iPSC-derived neurons. These findings suggest the involvement of PDE4 genes in the pathophysiology of schizophrenia and underscore the importance of studying the genetic basis of neuropsychiatric disorders.

Genes operates under an open-access policy, ensuring that all published articles are freely available to researchers worldwide. This model promotes the rapid dissemination of scientific findings and facilitates collaboration among researchers in the field. By contributing to this Special Issue, authors can benefit from the journal's wide reach and impact within the scientific community.

The deadline for submitting manuscripts to the Special Issue on the genetic basis of neuropsychiatric disorders is May 11, 2024. Researchers interested in contributing to this important collection of articles are encouraged to visit the Genes website for more information on the submission process and requirements. This Special Issue presents a unique opportunity to advance our understanding of the genetic factors underlying neuropsychiatric disorders and pave the way for improved diagnostic and therapeutic strategies.